Nutex Health, Inc. (NUTX) vs Stoke Therapeutics, Inc. (STOK)
A side-by-side comparison of Nutex Health, Inc. and Stoke Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NUTX
Nutex Health, Inc.
$221.01HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
STOK
Stoke Therapeutics, Inc.
$24.19HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — NUTX vs STOK
growth of $100 · dividends reinvested · last 7yNUTX -24.6% (-4.0%/yr)STOK -1.0% (-0.1%/yr)STOK compounded faster over this window
NUTX STOK
NUTX vs STOK: by the numbers
- •STOK is the larger company ($1.56B vs $1.52B market cap).
- •NUTX is profitable (21.25% net margin) while STOK runs a net loss (-753.60%).
Metrics side by side
Valuation
| Metric | NUTX | STOK |
|---|---|---|
| P/E ratio | 8.74 | N/A |
| Forward P/E | 7.95 | N/A |
| P/S ratio | 1.80 | 56.57 |
| P/B ratio | 3.86 | 4.52 |
| EV / EBITDA | 4.32 | N/A |
| FCF yield | 18.03% | N/A |
Profitability
| Metric | NUTX | STOK |
|---|---|---|
| Gross margin | 51.26% | 100.00% |
| Operating margin | 31.49% | -11.16% |
| Net margin | 21.25% | -753.60% |
| ROE | 45.63% | -60.17% |
| ROIC | 33.76% | -63.12% |
Growth (annualized)
| Metric | NUTX | STOK |
|---|---|---|
| Revenue CAGR (5Y) | 37.66% | N/A |
| EPS CAGR (5Y) | -14.73% | N/A |
| Total return CAGR (5Y) | -18.99% | -0.24% |
Frequently asked
- Is NUTX or STOK more profitable?
- NUTX runs the higher net margin — NUTX at 21.25% versus STOK at -753.60%.
- How have NUTX and STOK total returns compared?
- Over the past 5 years, NUTX delivered -18.99% and STOK delivered -0.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Nutex Health P/E ratioNutex Health ROEStoke Therapeutics ROENutex Health operating marginStoke Therapeutics operating marginNutex Health revenue growthStoke Therapeutics revenue growthNutex Health free cash flowStoke Therapeutics free cash flow
Nutex Health & Stoke Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.